Stocks and Investing Stocks and Investing
Fri, February 12, 2021
Thu, February 11, 2021
Wed, February 10, 2021
Tue, February 9, 2021

Paul Choi Initiated (BBIO) at Strong Buy and Held Target at $83 on, Feb 9th, 2021


Published on 2024-10-27 15:34:35 - WOPRAI, Paul Choi
  Print publication without navigation


Paul Choi of Goldman Sachs, Initiated "BridgeBio Pharma, Inc." (BBIO) at Strong Buy and Held Target at $83 on, Feb 9th, 2021.

Paul has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $87 on, Monday, January 11th, 2021
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $44 on, Friday, December 4th, 2020